ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Conte Institute Leafs Scientific Effort On Central Europe Environmental Clean-Up

March 19, 1993

In Brief: Children’s Hospital Of Boston Names Pizzo Physician-In-chief; Lynch Wins Bristol Award

March 22, 1996

CIS Celebrates 15th Anniversary, Praised By M. Quayle

December 6, 1991

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004